Literature DB >> 27238944

Indian hepatitis C drug patent decision shakes public health community.

Ellen F M 't Hoen1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27238944     DOI： 10.1016/S0140-6736(16)30656-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Essential medicines for universal health coverage.

Authors:  Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich
Journal:  Lancet       Date:  2016-11-08       Impact factor: 79.321

2.  Trends in medicines procurement by the Brazilian federal government from 2006 to 2013.

Authors:  Tatiana Chama Borges Luz; Claudia Garcia Serpa Osorio-de-Castro; Rachel Magarinos-Torres; Bjorn Wettermark
Journal:  PLoS One       Date:  2017-04-07       Impact factor: 3.240

3.  Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016.

Authors:  Ellen Fm 't Hoen; Jacquelyn Veraldi; Brigit Toebes; Hans V Hogerzeil
Journal:  Bull World Health Organ       Date:  2018-02-05       Impact factor: 9.408

4.  Pathways to ensure universal and affordable access to hepatitis C treatment.

Authors:  Caitlin H Douglass; Alisa Pedrana; Jeffrey V Lazarus; Ellen F M 't Hoen; Radi Hammad; Ricardo Baptista Leite; Andrew Hill; Margaret Hellard
Journal:  BMC Med       Date:  2018-10-09       Impact factor: 8.775
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.